Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-05
1998-04-14
Ketter, James
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, A61K 3818, C07K 1451
Patent
active
057391076
ABSTRACT:
Disclosed are methods and compositions for maintaining the integrity of the gastrointestinal tract luminal lining in a mammal, including (1) limiting epithelial cell proliferation, (2) inhibiting ulcerative lesion formation, (3) inhibiting inflammation normally associated with ulcerative diseases, and (4) stimulating the repair of ulcerative lesions and the regeneration of the luminal tissue. The methods and compositions include a therapeutically effective amount of a morphogen as defined herein.
REFERENCES:
patent: 4806523 (1989-02-01), Bentz et al.
patent: 4877864 (1989-10-01), Wang et al.
patent: 4919939 (1990-04-01), Baker
patent: 4968590 (1990-11-01), Kuberasampath et al.
patent: 4971952 (1990-11-01), Bentz et al.
patent: 4975526 (1990-12-01), Kuberasampath et al.
patent: 4983581 (1991-01-01), Antoniades et al.
patent: 5008240 (1991-04-01), Bentz et al.
patent: 5011691 (1991-04-01), Oppermann et al.
patent: 5013649 (1991-05-01), Wang et al.
patent: 5043329 (1991-08-01), Lichtenberger
patent: 5091513 (1992-02-01), Huston et al.
patent: 5102870 (1992-04-01), Florine et al.
patent: 5106626 (1992-04-01), Parsons et al.
patent: 5108753 (1992-04-01), Kuberasampath et al.
patent: 5108989 (1992-04-01), Amento et al.
patent: 5110795 (1992-05-01), Hahn
patent: 5118791 (1992-06-01), Burnier et al.
patent: 5135915 (1992-08-01), Czarniecki et al.
patent: 5141905 (1992-08-01), Rosen et al.
patent: 5234908 (1993-08-01), Szabo et al.
Szabo et al. (1977), "Pathogenesis of Duodenal Ulcer, Gastric Hyperacidity Caused by Propionitrile and Cyteamine in Rats," Res. Comm. Chem. Pathol. Pharmacol., 16:311-323.
Onderdonk et al. (1979), "Bacteriological Studies of Experimental Ulcerative Colitis," Am. J. Clin. Nutr., 32:258-265.
Clark et al. (1985), "Coregulation of Collagenase and Collagenase Inhibitor Production by Phorbol Myristate Acetate in Human Skin Fibroblasts", Arch. Bio. Chem. Biophys., 241:36-44.
Onderdonk (1985), "Experimental Models for Ulcerative Colitis," Dig. Diseases Sci., 30:40S-44S.
Pihan et al. (1985), "Biliary and Pancreatic Secretions Influence Experimental Duodenal Ulcer Without Affecting Gastric Secretion in the Rat," Dig. Diseases Sci., 30:240-246.
Forage et al. (1986), "Cloning and Sequence Analysis of cDNA Species Coding for the Two Subunits of Inhibin from Bovine Follicular Fluid," Proc. Natl. Acad. Sci. USA 83:3091-3095.
Massague (1987), "The TGF-.beta. Family of Growth and Differentiation Factors," Cell 49:437-438.
Cheifetz et al. (1988), "A Surface Component on GH3 Pituitary Cells That Recognizes Transforming Growth Factor-B, Activin, and Inhibin," J. Biol. Chem. 263, (No. 33) 17725-17728.
George et al. (1988), "Current Methods in Sequence Comparison and Analysis" Macromolecular Sequencing and Synthesis Selected Methods and Applications, Ch. 12, 127-149.
Heath et al. (1988), "Regulatory Factors of Embryonic Stem Cells," J. Cell Sci. Supp. 10:257-266.
Krummel et al. (1988), "Transforming Growth Factor Beta (TGF-B) Induces Fibrosis in a Fetal Wound Model," Journal of Pediatric Surgery 23:647-652.
Pepinsky et al. (1988), "Proteolytic Processing of Mullerian Inhibiting Substance Produces a Transforming Growth Factor-.beta.-like Fragment," J. Biol. Chem. 263:18961-18964.
Postlethwaite et al. (1988), "Modulation of Fibroblast Functions by Interleukin 1: Increased Steady-State Accumulation of Type I Procollagen Messenger RNAs and Stimulation of Other Functions but Not Chemotaxis by Human Recombinant Interleukin 1.alpha. and .beta.", J. Cell Biol., 103:311-318.
Sugino et al. (1988), "Identification of a Specific Receptor for Erythroid Differentiation Factor on Follicular Granulosa Cell," J. Biol. Chem. 263:(No. 30); 15249-15252.
Williams (1988), "The Role of Diffusible Molecules in Regulating the Cellular Differentiation of Dictyostelium discoideum," Development 103:1-16.
Postlethwaite et al. (1989), "Stimulation of Glycosaminoglycan Synthesis in Cultured Human Dermal Fibroblasts by Interleukin 1", J. Clin. Invest., 83:629-636.
Sporn et al. (1989), "Transforming Growth Factor-.beta.," JAMA 262:7; 938-941.
Wahl et al. (1989), "Inflammatory and Immunomodulatory Roles of TGF-.beta.," Immunol. Today 10:258-261.
Border et al. (1990), "Suppression of Experimental Glomerulonephritis by Antiserum Against Transforming Growth Factor B1," Nature 346:371-374.
Coffman et al. (1990), "Xotch, the Xenopus Homolog of Drosophila notch," Science 249:1438-1441.
Gennaro (1990) Remington's Pharmaceutical Sciences (Mack Pubs., N.Y.).
Gray et al. (1990), "Requirement for Activin A and Transforming Growth Factor-B1 Pro-Regions in Homodimer Assembly," Science 247:1328-1330.
Lefer et al. (1990), "Mediation of Cardioprotection by Transforming Growth Factor-B," Science 249:61-64.
Okayasu et al. (1990), "A Novel Method in the Induction of Reliable Experimental Acute and Chronic Ulcerative Colitis in Mices," Gastroenterology, 98:694-702.
Okuda et al. (1990), "Elevated Expression of Transforming Growth Factor-B and Proteoglycan Production in Experimental Glomerulonephritis, Possible Role in Expansion of the Mesangial Extracellular Matrix," J. Clin. Invest. 86:453-462.
Sonis et al. (1990), "An Animal Model for Mucositis Induced by Cancer Chemotherapy," Oral Surg. Oral Med. Oral Pathol. 69:437-443.
Van Den Eijnden-Van Raaij et al. (1990), "Activin-Like Factor from a Xenopus laevis Cell Line Responsible for Mesoderm Induction," Nature 345:732-734.
Caplan (1991), "Mesenchymal Stem Cells," J. Orthop. Res. 9:641-650.
Castilla et al. (1991), "Transforming Growth Factors B1 and .alpha. in Chronic Liver Disease," The New England Journal of Medicine 324:933-939.
Fava et al. (1991), "Transforming Growth Factor .beta.1 (TGF-.beta.1) Induced Neutrophil Recruitment to Synovial Tissues: Implications for TGF-.beta.-driven Synovial Inflammation and Hyperplasia," J. Exp. Med., 173:1121-1132.
Fausto et al. (1991), "Effects of TGF-.beta.s in the Liver: Cell Proliferation an Fibrogenesis," 157 Ciba Found. Symp. 165-174.
Gallagher (1991), "Oral Mucous Membrane Reactions to Drugs and Chemicals," Curr. Opn. in Dent., 1:777-782.
Khalil et al. (1991), "Increased Production and Immunohistochemical Localization of Transforming Growth Factor-B in Idiopathic Pulmonary Fibrosis," Am. J. Respir. Cell Mol. Biol. 5:155-162.
Kuruvilla et al. (1991), "Protective Effect of Transforming Growth Factor B1 on Experimental Autoimmune Diseases in Mice," Proc. Natl. Acad. Sci. USA 88:2918-2921.
Whitby et al. (1991), "Immunohistochemical Localization of Growth Factors in Fetal Wound Healing," Development Biology 147:207-215.
Border et al. (1992), "Transforming Growth Factor-.beta. in Disease: The Dark Side of Tissue Repair," J. Clin. Invest. 90:1-7.
Wahl (1992), "Transforming Growth Factor Beta (TGF-.beta.) in Inflammation: A Cause and A Cure," J. Clin. Immun. 12:61-74.
Estevez et al. (1993), "The daf-4 Gene Encodes a Bone Morphogenetic Protein Receptor Controlling C. Elegans Dauer Larva Development," Nature 365:644-649.
Perides et al. (1993), "Osteogenic Protein-1 Regulates L1 and Neural Cell Adhesion Molecule Gene Expression in Neural Cells," J. Biol. Chem. 268:197-25205.
Wahl et al. (1993), "Reversal of Acute and Chronic Synovial Inflammation by Anti-Transforming Growth Factor .beta.," J. Exp. Med. 177:225-230.
Wall et al. (1993), "Biosynthesis and In Vivo Localization of the Decapentaplegic-Vg-Related Protein, DVR-6 (Bone Morphogenetic Protein-6)," J. Cell Biol. 120(2):493-502.
Kinglsey (1994), "The TGF-B Superfamily: New Members, New Receptors, and New Genetic Tests of Function in Different Organisms," Genes & Development 8:133-146.
Koenig et al. (1994), "Characterization and Cloning of a Receptor for BMP-2 and BMP-4 From NIH 3T3 Cells," Mol. Cell Biol. 14:5961-5974.
Perides et al. (1994), "Regulation of Neural Cell Adhesion Molecule and L1 by the Transforming Growth Factor-.beta. Superfamily," J. Biol. Chem. 269:765-770.
Sanderson et al. (1995), "Hepatic Expression of Mature Transforming Growth Factor .beta.1 in Transgenic Mice Results in Multiple Tissue Lesions," Proc. Natl. Acad. Sci. USA 92:2572-2576.
Sampath et al. (1983), "Homology of Bon
Charette Marc F.
Cohen Charles M.
Kuberasampath Thangavel
Oppermann Hermann
Ozkaynak Engin
Creative BioMolecules, Inc.
Ketter James
Schwartzman Robert
LandOfFree
Morphogen treatment of gastrointestinal ulcers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Morphogen treatment of gastrointestinal ulcers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morphogen treatment of gastrointestinal ulcers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-634595